I‐Wei Chang

1.2k total citations
66 papers, 878 citations indexed

About

I‐Wei Chang is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I‐Wei Chang has authored 66 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 19 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I‐Wei Chang's work include Esophageal Cancer Research and Treatment (11 papers), Esophageal and GI Pathology (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). I‐Wei Chang is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Esophageal and GI Pathology (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). I‐Wei Chang collaborates with scholars based in Taiwan, United States and Sweden. I‐Wei Chang's co-authors include Chien‐Feng Li, Hong-Lin He, Wen‐Jeng Wu, Tingfeng Wu, Hsuan‐Ying Huang, Sung‐Wei Lee, Chi‐Yang Chang, Ming-Tse Sung, Wen‐Lun Wang and Ching‐Tai Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Scientific Reports.

In The Last Decade

I‐Wei Chang

60 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Wei Chang Taiwan 19 335 231 213 195 185 66 878
Csilla Páska Hungary 16 408 1.2× 226 1.0× 103 0.5× 156 0.8× 260 1.4× 27 1.1k
Chong Lu China 22 571 1.7× 255 1.1× 190 0.9× 268 1.4× 304 1.6× 56 1.2k
Jinbo Gao China 19 588 1.8× 201 0.9× 245 1.2× 257 1.3× 292 1.6× 66 1.1k
Martine Mergey France 15 265 0.8× 161 0.7× 403 1.9× 342 1.8× 106 0.6× 18 855
Delphine Bonnet France 17 250 0.7× 115 0.5× 183 0.9× 241 1.2× 119 0.6× 53 1.0k
Nobumi Suzuki Japan 16 303 0.9× 146 0.6× 311 1.5× 216 1.1× 94 0.5× 49 806
Yoshihiro Nakazato Japan 14 287 0.9× 137 0.6× 244 1.1× 643 3.3× 191 1.0× 30 1.2k
Xi Xu China 18 427 1.3× 111 0.5× 96 0.5× 281 1.4× 314 1.7× 50 947
Yuli Wang China 14 196 0.6× 182 0.8× 114 0.5× 195 1.0× 73 0.4× 54 714
Motonari Nomura Japan 14 368 1.1× 187 0.8× 194 0.9× 152 0.8× 100 0.5× 56 819

Countries citing papers authored by I‐Wei Chang

Since Specialization
Citations

This map shows the geographic impact of I‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Wei Chang more than expected).

Fields of papers citing papers by I‐Wei Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Wei Chang. The network helps show where I‐Wei Chang may publish in the future.

Co-authorship network of co-authors of I‐Wei Chang

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Wei Chang. A scholar is included among the top collaborators of I‐Wei Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Wei Chang. I‐Wei Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Yao‐Chun, Chi-Yi Chen, Cheng‐Hao Tseng, et al.. (2024). Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial. Clinical and Molecular Hepatology. 31(1). 213–226.
2.
Lu, Chien-Hung, Weu Wang, Yu‐Chuan Li, et al.. (2024). Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease. Obesity Surgery. 34(12). 4393–4404. 2 indexed citations
3.
Chang, I‐Wei, et al.. (2024). Sparganosis presenting as a subcutaneous mass of the thigh. Polish Journal of Pathology. 75(2). 166–168. 1 indexed citations
4.
Chang, I‐Wei, et al.. (2023). Eight-year chronic wound caused by Tarlov’s cyst: a case report. Journal of Medical Case Reports. 17(1). 525–525. 1 indexed citations
5.
Wang, Weu, Ching-Wen Chang, I‐Wei Chang, et al.. (2023). Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. Journal of Clinical Medicine. 12(11). 3730–3730. 3 indexed citations
6.
7.
Hsu, Yao‐Chun, Vithika Suri, Mindie H. Nguyen, et al.. (2022). Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation. Gastroenterology. 162(4). 1160–1170.e1. 46 indexed citations
8.
Wang, Wen‐Lun, I‐Wei Chang, Sin‐Hua Moi, et al.. (2021). Assessment of tumor extension to the ductal system of submucosal glands in patients with superficial esophageal squamous neoplasms: Implications for endoscopic resection. Journal of Thoracic and Cardiovascular Surgery. 163(6). 1951–1960.e3. 2 indexed citations
9.
Sheen‐Chen, Shyr‐Ming, et al.. (2020). Advanced Burkitt's lymphoma in a man presenting with a breast tumor: A case report. The Breast Journal. 26(11). 2250–2251.
10.
Kao, Wei‐Yu, I‐Wei Chang, Chi‐Long Chen, et al.. (2020). Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity Surgery. 30(4). 1249–1257. 18 indexed citations
11.
Wang, Wen‐Lun, I‐Wei Chang, Chien-Chuan Chen, et al.. (2018). The in vivo tissue effect of endoscopic balloon‐based radiofrequency ablation in treating esophageal squamous cell neoplasia. United European Gastroenterology Journal. 6(5). 656–661. 2 indexed citations
12.
Tsai, Chin‐Chuan, Chun‐Ru Hsu, I‐Wei Chang, et al.. (2018). Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies. BMC Complementary and Alternative Medicine. 18(1). 96–96. 31 indexed citations
13.
Chang, I‐Wei, et al.. (2018). SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer. International Journal of Medical Sciences. 15(4). 376–384. 19 indexed citations
14.
Tsai, Ming‐Shian, Po‐Huang Lee, Cheuk‐Kwan Sun, et al.. (2018). Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target. Experimental & Molecular Medicine. 50(1). e426–e426. 16 indexed citations
15.
Chang, I‐Wei, Ching‐Yih Lin, Ding‐Ping Sun, et al.. (2017). High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers. Journal of Cancer. 8(14). 2756–2764. 12 indexed citations
16.
Chang, I‐Wei, Chien‐Feng Li, Victor C. Lin, et al.. (2016). Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders. Journal of Cancer. 7(11). 1541–1549. 22 indexed citations
17.
Chang, I‐Wei, Yuhui Wang, Wen‐Jeng Wu, et al.. (2016). Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder. Journal of Cancer. 7(3). 304–313. 10 indexed citations
18.
Chang, I‐Wei, Victor C. Lin, Chih‐Hsin Hung, et al.. (2015). GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. World Journal of Urology. 33(11). 1777–1789. 24 indexed citations
19.
Chang, I‐Wei, Chao‐Tien Hsu, Jui‐Wei Lin, & Chih‐Hsin Hung. (2013). The prognostic impact of MGMT expression on low-grade gangliogliomas: a clinicopathological and immunohistochemical study. Folia Neuropathologica. 4(4). 275–282. 7 indexed citations
20.
Lin, Victor C., et al.. (2013). Clear cell adenocarcinoma of the renal pelvis: an extremely rare neoplasm of the upper urinary tract. Polish Journal of Pathology. 4(4). 308–311. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Csilla Páska Breakdown of academic impact, for papers by Chong Lu Breakdown of academic impact, for papers by Jinbo Gao Breakdown of academic impact, for papers by Martine Mergey Breakdown of academic impact, for papers by Delphine Bonnet Breakdown of academic impact, for papers by Nobumi Suzuki Breakdown of academic impact, for papers by Yoshihiro Nakazato Breakdown of academic impact, for papers by Xi Xu Breakdown of academic impact, for papers by Yuli Wang Breakdown of academic impact, for papers by Motonari Nomura
Rankless by CCL
2026